1. Efficacy of adjuvant weight loss medication after bariatric surgery
Zubaidah Nor Hanipah, M.D., Elie C. Nasr, B.A., Emre Bucak, M.D., Philip R. Schauer, M.D., Ali Aminian, M.D., Stacy A. Brethauer, M.D., Derrick Cetin, D.O. 
Surgery for Obesity and Related Diseases 
Volume 14, Issue 1, Pages (January 2018)
DOI: /j.soard
Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions

2. Fig. 1
(A) Mean weight. (B) Mean body mass index (BMI). LAGB = laparoscopic adjustable gastric band; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy.
Surgery for Obesity and Related Diseases  , 93-98DOI: ( /j.soard )
Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions

3. Fig. 2
(A) Total weight loss (TWL)>5% at 3 months after adjuvant pharmacotherapy. (B) TWL>5% at 12 months after adjuvant pharmacotherapy. (C) TWL>10% at 3 months after adjuvant pharmacotherapy. (D) TWL>10% at 12 months after adjuvant pharmacotherapy. LAGB = laparoscopic adjustable gastric band; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy.
Surgery for Obesity and Related Diseases  , 93-98DOI: ( /j.soard )
Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions